Thirteen-State Coalition Targets Veterinary Distribution Consolidation
The legal complaint lodged by the Federal Trade Commission alongside thirteen state attorneys general represents a decisive regulatory strike against consolidation in the animal healthcare supply chain. Targeting the $3.5 billion divestiture agreed upon in February, federal litigators contend that merging MWI Animal Health with Covetrus would unite the top two national wholesalers serving companion animal and livestock practitioners.
According to the regulatory filing, MWI and Covetrus currently engage in vigorous price competition, routinely deploying targeted discounts and volume rebates to secure contracts from independent veterinary practices and major clinic networks. Regulators warn that eliminating this competitive rivalry would empower the combined entity to inflate wholesale pricing unchecked.
*“The proposed transaction would combine the two largest distributors of veterinary medicines and clinic supplies in the US, effectively wiping out head-to-head competition.” Federal Trade Commission*
Wall Street Resilience and Alternative Divestiture Contingencies
Despite the aggressive litigation posture adopted in Washington and New York, equity investors responded calmly to the enforcement action. Financial analysts at J.P.

















